Literature DB >> 30719655

Landmark analysis: A primer.

Charity J Morgan1.   

Abstract

Mesh:

Year:  2019        PMID: 30719655     DOI: 10.1007/s12350-019-01624-z

Source DB:  PubMed          Journal:  J Nucl Cardiol        ISSN: 1071-3581            Impact factor:   5.952


× No keyword cloud information.
  5 in total

Review 1.  Time-dependent covariates in the Cox proportional-hazards regression model.

Authors:  L D Fisher; D Y Lin
Journal:  Annu Rev Public Health       Date:  1999       Impact factor: 21.981

Review 2.  Landmark analysis at the 25-year landmark point.

Authors:  Urania Dafni
Journal:  Circ Cardiovasc Qual Outcomes       Date:  2011-05

3.  On the relationship between response to treatment and survival time.

Authors:  M Buyse; P Piedbois
Journal:  Stat Med       Date:  1996-12-30       Impact factor: 2.373

Review 4.  An unjustified benefit: immortal time bias in the analysis of time-dependent events.

Authors:  Andreas Gleiss; Rainer Oberbauer; Georg Heinze
Journal:  Transpl Int       Date:  2017-11-09       Impact factor: 3.782

5.  Analysis of survival by tumor response.

Authors:  J R Anderson; K C Cain; R D Gelber
Journal:  J Clin Oncol       Date:  1983-11       Impact factor: 44.544

  5 in total
  18 in total

1.  Cumulative probabilities of live birth across multiple complete IVF/ICSI cycles: a call for attention.

Authors:  Juan J Tarín; Eva Pascual; Santiago Pérez-Hoyos; Raúl Gómez; Miguel A García-Pérez; Antonio Cano
Journal:  J Assist Reprod Genet       Date:  2019-12-05       Impact factor: 3.412

2.  Long-term oncological outcomes after local excision of T1 rectal cancer.

Authors:  J W A Leijtens; L J H Smits; T W A Koedam; R G Orsini; S M van Aalten; M Verseveld; P G Doornebosch; E J R de Graaf; J B Tuynman
Journal:  Tech Coloproctol       Date:  2022-08-27       Impact factor: 3.699

3.  Five-Year Outcomes of FOLFIRINOX vs Gemcitabine as Adjuvant Therapy for Pancreatic Cancer: A Randomized Clinical Trial.

Authors:  Thierry Conroy; Florence Castan; Anthony Lopez; Anthony Turpin; Meher Ben Abdelghani; Alice C Wei; Emmanuel Mitry; James J Biagi; Ludovic Evesque; Pascal Artru; Thierry Lecomte; Eric Assenat; Lucile Bauguion; Marc Ychou; Olivier Bouché; Laure Monard; Aurélien Lambert; Pascal Hammel
Journal:  JAMA Oncol       Date:  2022-09-01       Impact factor: 33.006

4.  Estimated GFR Slope Across CKD Stages in Primary Hyperoxaluria Type 1.

Authors:  Prince Singh; Lisa E Vaughan; Phillip J Schulte; David J Sas; Dawn S Milliner; John C Lieske
Journal:  Am J Kidney Dis       Date:  2022-03-16       Impact factor: 11.072

5.  Palbociclib plus endocrine therapy significantly enhances overall survival of HR+/HER2- metastatic breast cancer patients compared to endocrine therapy alone in the second-line setting: A large institutional study.

Authors:  Min Jin Ha; Akshara Singareeka Raghavendra; Nicole M Kettner; Wei Qiao; Senthil Damodaran; Rachel M Layman; Kelly K Hunt; Yu Shen; Debu Tripathy; Khandan Keyomarsi
Journal:  Int J Cancer       Date:  2022-03-03       Impact factor: 7.316

6.  Comparison of outcomes between immediate implantbased and autologous reconstruction: 15-year, single-center experience in a propensity score-matched Chinese cohort.

Authors:  Shanshan He; Bowen Ding; Gang Li; Yubei Huang; Chunyong Han; Jingyan Sun; Qingfeng Huang; Jing Liu; Zhuming Yin; Shu Wang; Jian Yin
Journal:  Cancer Biol Med       Date:  2021-12-01       Impact factor: 5.347

7.  Renal Replacement Therapy in Patients With Stage IV Cancer Admitted to the Intensive Care Unit With Acute Kidney Injury at a Comprehensive Cancer Center Was Not Associated With Survival.

Authors:  Ala Abudayyeh; Juhee Song; Maen Abdelrahim; Ibrahim Dahbour; Valda D Page; Shouhao Zhou; Chan Shen; Bo Zhao; Rima N Pai; Jaya Amaram-Davila; Joanna-Grace Manzano; Marina C George; Sriram Yennu; Sreedhar A Mandayam; Joseph L Nates; Alvin H Moss
Journal:  Am J Hosp Palliat Care       Date:  2020-01-27       Impact factor: 2.500

8.  Association between selective serotonin reuptake inhibitor and risk of peripheral artery disease in diabetes mellitus: Propensity score matching and landmark analysis.

Authors:  Kai-Hua Chen; Ting-Yao Wang; Chuan-Pin Lee; Yao-Hsu Yang; Roger S McIntyre; Mehala Subramaniapillai; Yena Lee; Vincent Chin-Hung Chen
Journal:  Medicine (Baltimore)       Date:  2022-05-06       Impact factor: 1.817

9.  A comprehensive analysis of tumor microenvironment-related genes in colon cancer.

Authors:  R Luo; W Guo; H Wang
Journal:  Clin Transl Oncol       Date:  2021-03-10       Impact factor: 3.405

10.  Thrombospondin-2 and LDH Are Putative Predictive Biomarkers for Treatment with Everolimus in Second-Line Metastatic Clear Cell Renal Cell Carcinoma (MARC-2 Study).

Authors:  Philip Zeuschner; Sebastian Hölters; Michael Stöckle; Barbara Seliger; Anja Mueller; Hagen S Bachmann; Viktor Grünwald; Daniel C Christoph; Arnulf Stenzl; Marc-Oliver Grimm; Fabian Brüning; Peter J Goebell; Marinela Augustin; Frederik Roos; Johanna Harde; Iris Benz-Rüd; Michael Staehler; Kerstin Junker
Journal:  Cancers (Basel)       Date:  2021-05-25       Impact factor: 6.639

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.